About
Neurological Compounds
Areas of Focus
Categories
Small Molecule PharmaceuticalSeattle/Pacific Northwest
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
65
By Phase
PHASE2: 1PHASE1: 2
By Status
COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06769659Lead Sponsor
A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures
PHASE2Recruiting
10 participants
Started: Mar 11, 2025 · Completed: May 30, 2026
NCT06525649Lead Sponsor
A Double Blind, Randomized, Cross-over Study Examining the Suppression of the Photoparoxysmal EEG Response With NPT 2042
PHASE1Completed
5 participants
Started: Aug 21, 2024 · Completed: Jun 26, 2025
NCT05503511Lead Sponsor
Safety and Pharmacokinetic Study of NPT 2042 Soft-gelatin Capsules Administered Orally to Healthy Adult Subjects
PHASE1Completed
50 participants
Started: Oct 20, 2022 · Completed: Mar 30, 2023
Locations (1)
Headquarters
Yachats, OR, United States
Map
Loading map...